dctd-lung-spore (Abstracts)

Abstracts

Each registered participant may submit one electronic abstract.  However, it is not required that you submit an abstract to attend the meeting.   

Abstracts are due on May 1, 2019.  Below are the steps required to submit an electronic abstract at the following link: https://bit.ly/2Osm5Gi.  

 

Step 1:  Enter the title, the authors and their affiliations.  If there are more than 10 authors, please upload a list in a Word or Excel document to Tam Walton. Do not upload the abstract.

Step 2: Copy and paste the body of your text into the form.  Please limit your submission to one page or 3,000 characters. Do not include your title in the abstract body.  There are no images allowed. 

Step 3:  Code your abstract appropriately based on the following meeting categories:

  • KRAS, LKB1 and Related Pathways
  • Therapeutic Resistance
  • Clinical Trials and Cooperative Group Efforts
  • Novel Targets
  • Premalignancy, Risk Stratification and Chemoprevention
  • EGFR Fusions and Other Signaling Pathways
  • Molecular Profiling and Biomarkers
  • Small Cell Lung Cancer
  • Immunotherapy
  • Patient/Research Advocate issues

Your category may be changed by the meeting chairs.

 

Step 4:  Hit the submit button to email your submission.

 

If you have any questions, Tam Walton at 240-276-5626.